Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus

Hyun Young Woo, Jong Young Choi, Seung Kew Yoon, Dong Jin Suh, Seung Woon Paik, Kwang Hyub Han, Soon Ho Um, Byung Ik Kim, Heon Ju Lee, Mong Cho, Chun Kyon Lee, Dong Joon Kim, Jae Seok Hwang

Clin Mol Hepatol. 2014;20(2):168-176. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.168

View: 8070 Download: 61 Web of Science: 4 Crossref: 2

Efficacy and safety of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma as first-line therapy

Myung Jin Oh, Heon Ju Lee, Si Hyung Lee

Clin Mol Hepatol. 2013;19(3):288-299. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.288

View: 8255 Download: 75 Crossref: 10

Case Report

A case of peripheral gangrene and osteomyelitis secondary to terlipressin therapy in advanced liver disease

Heon Ju Lee, Myung Jin Oh

Clin Mol Hepatol. 2013;19(2):179-184. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.179

View: 7028 Download: 77 Crossref: 9

Original Article

A study of hepatitis B virus reactivation associated with rituximab therapy in real-world clinical practice: a single-center experience

Myung Jin Oh, Heon Ju Lee

Clin Mol Hepatol. 2013;19(1):51-59. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.51

View: 7465 Download: 78 Web of Science: 24 Crossref: 23

Peginterferon alpha and ribavirin combination therapy in patients with hepatitis C virus-related liver cirrhosis

Kyung Hoon Kim, Byoung Kuk Jang, Woo Jin Chung, Jae Seok Hwang, Young Oh Kweon, Won Young Tak, Heon Ju Lee, Chang Hyeong Lee, Jeong Ill Suh

Clin Mol Hepatol. 2011;17(3):220-225. Published online September 30, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.3.220

View: 7093 Download: 53 Crossref: 11

1 |

Viewed By 5387	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5341	MAFLD: How is it different from NAFLD?
Viewed By 5228	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3910	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3877	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search